Stay updated on NNC0165-1875 and Semaglutide Combo in Obesity: Clinical Trial
Sign up to get notified when there's something new on the NNC0165-1875 and Semaglutide Combo in Obesity: Clinical Trial page.

Latest updates to the NNC0165-1875 and Semaglutide Combo in Obesity: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedNew revision v3.3.3 dated 2025-12-18 adds core trial data sections (Adverse Events, Outcome Measures/Results, Baseline Characteristics, Participant Flow) and Study Status; the older revision v3.3.2's HHS Vulnerability Disclosure is removed.SummaryDifference1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history now shows 'Results Submitted', replacing the previous 'No Results Posted' status.SummaryDifference0.1%

- Check48 days agoChange DetectedThe Record History page shows a new revision entry v3.3.2 and the previous v3.2.0 entry has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe government funding/operating status notice on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check70 days agoChange DetectedA new version entry (Version 21) appears in the Record History, reflecting an updated submission dated 2024-09-05.SummaryDifference0.1%

- Check98 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference12%

Stay in the know with updates to NNC0165-1875 and Semaglutide Combo in Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC0165-1875 and Semaglutide Combo in Obesity: Clinical Trial page.